Literature DB >> 24595500

Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients.

Ben Zhang1, Peter Y Zavalij, Lyle Isaacs.   

Abstract

We report the synthesis and X-ray crystal structures of three acyclic CB[n]-type molecular containers (2a, 2h, 2f) that differ in the charge on their solubilizing groups (SO3(−), OH, NH3(+)). The X-ray crystal structures of compounds 2h and 2f reveal a self-folding of the ArOCH2CH2X wall into the cavity driven by π–π interactions, H-bonds and ion–dipole interactions. The need to reverse this self-folding phenomenon upon guest binding decreases the affinity of 2h and 2f toward cationic guests in water relative to 2a as revealed by direct (1)H NMR and UV/Vis titrations as well as UV/Vis competition experiments. We determined the pKa of 6-aminocoumarin 7 (pKa = 3.6) on its own and in the presence anionic, neutral, and cationic hosts (2a: pKa = 4.9; 2h: pKa = 4.1; 2f, pKa = 3.4) which reflect in part the relevance of direct ion–ion interactions between the arms of the host and the guest toward the recognition properties of acyclic CB[n]-type containers. Finally, we showed that the weaker binding affinities measured for neutral and positively charged hosts 2h and 2f compared to anionic 2a results in a decreased ability to act as solubilizing agents for either cationic (tamoxifen), neutral (17α-ethynylestradiol), or anionic (indomethacin) drugs in water. The results establish that acyclic CB[n] compounds that bear anionic solubilizing groups are most suitable for development as general purpose solubilizing excipients for insoluble pharmaceutical agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595500      PMCID: PMC4035228          DOI: 10.1039/c3ob42603c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  67 in total

Review 1.  Prodrug strategies to overcome poor water solubility.

Authors:  Valentino J Stella; Kwame W Nti-Addae
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 2.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 3.  Oral lipid-based formulations.

Authors:  David J Hauss
Journal:  Adv Drug Deliv Rev       Date:  2007-05-26       Impact factor: 15.470

4.  Supramolecular polymeric hydrogels.

Authors:  Eric A Appel; Jesús del Barrio; Xian Jun Loh; Oren A Scherman
Journal:  Chem Soc Rev       Date:  2012-08-13       Impact factor: 54.564

5.  Supramolecular ladders from dimeric cucurbit[6]uril.

Authors:  James B Wittenberg; Peter Y Zavalij; Lyle Isaacs
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-18       Impact factor: 15.336

6.  Diastereoselective formation of glycoluril dimers: isomerization mechanism and implications for cucurbit[n]uril synthesis.

Authors:  Arindam Chakraborty; Anxin Wu; Dariusz Witt; Jason Lagona; James C Fettinger; Lyle Isaacs
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

7.  para-Bridged symmetrical pillar[5]arenes: their Lewis acid catalyzed synthesis and host-guest property.

Authors:  Tomoki Ogoshi; Suguru Kanai; Shuhei Fujinami; Tada-aki Yamagishi; Yoshiaki Nakamoto
Journal:  J Am Chem Soc       Date:  2008-03-22       Impact factor: 15.419

8.  Photocontrol over cucurbit[8]uril complexes: stoichiometry and supramolecular polymers.

Authors:  Jesús del Barrio; Peter N Horton; Didier Lairez; Gareth O Lloyd; Chris Toprakcioglu; Oren A Scherman
Journal:  J Am Chem Soc       Date:  2013-08-06       Impact factor: 15.419

9.  Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit[n]uril.

Authors:  Yunjie Zhao; Damian P Buck; David L Morris; Mohammad H Pourgholami; Anthony I Day; J Grant Collins
Journal:  Org Biomol Chem       Date:  2008-11-06       Impact factor: 3.876

Review 10.  Salt formation to improve drug solubility.

Authors:  Abu T M Serajuddin
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

View more
  13 in total

1.  Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.

Authors:  Gaya Hettiarachchi; Soumen K Samanta; Shane Falcinelli; Ben Zhang; Damien Moncelet; Lyle Isaacs; Volker Briken
Journal:  Mol Pharm       Date:  2016-01-22       Impact factor: 4.939

2.  Cationic acyclic cucurbit[n]uril-type containers: synthesis and molecular recognition toward nucleotides.

Authors:  David Sigwalt; Peter Y Zavalij; Lyle Isaacs
Journal:  Supramol Chem       Date:  2016-04-13       Impact factor: 1.688

3.  Acyclic Cucurbit[n]uril-type Receptors: Preparation, Molecular Recognition Properties and Biological Applications.

Authors:  Shweta Ganapati; Lyle Isaacs
Journal:  Isr J Chem       Date:  2017-11-14       Impact factor: 3.333

4.  Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.

Authors:  Laura Gilberg; Ben Zhang; Peter Y Zavalij; Vladimir Sindelar; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2015-04-07       Impact factor: 3.876

5.  Molecular Containers Bind Drugs of Abuse in Vitro and Reverse the Hyperlocomotive Effect of Methamphetamine in Rats.

Authors:  Shweta Ganapati; Stephanie D Grabitz; Steven Murkli; Flora Scheffenbichler; Maíra I Rudolph; Peter Y Zavalij; Matthias Eikermann; Lyle Isaacs
Journal:  Chembiochem       Date:  2017-07-12       Impact factor: 3.164

6.  Triptycene Walled Glycoluril Trimer: Synthesis and Recognition Properties.

Authors:  Sandra Zebaze Ndendjio; Wenjin Liu; Nicolas Yvanez; Zihui Meng; Peter Y Zavalij; Lyle Isaacs
Journal:  New J Chem       Date:  2019-11-28       Impact factor: 3.591

7.  In Vitro and In Vivo Sequestration of Methamphetamine by a Sulfated Acyclic CB[n]-Type Receptor.

Authors:  Adam T Brockett; Chunlin Deng; Michael Shuster; Suvenika Perera; Delaney DiMaggio; Ming Cheng; Steven Murkli; Volker Briken; Matthew R Roesch; Lyle Isaacs
Journal:  Chemistry       Date:  2021-10-27       Impact factor: 5.236

8.  Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.

Authors:  Friederike Haerter; Jeroen Cedric Peter Simons; Urs Foerster; Ingrid Moreno Duarte; Daniel Diaz-Gil; Shweta Ganapati; Katharina Eikermann-Haerter; Cenk Ayata; Ben Zhang; Manfred Blobner; Lyle Isaacs; Matthias Eikermann
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

9.  Triazole functionalized acyclic cucurbit[n]uril-type receptors: host·guest recognition properties.

Authors:  Weijian Xue; Peter Y Zavalij; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2019-06-05       Impact factor: 3.876

10.  Acyclic Cucurbit[n]uril Dendrimers.

Authors:  David Sigwalt; Sarah Ahlbrand; Mingming Zhang; Brittany Vinciguerra; Volker Briken; Lyle Isaacs
Journal:  Org Lett       Date:  2015-11-23       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.